This article is for informational purposes only and does not constitute medical advice. Clinical trial eligibility and availability vary. Always consult a qualified healthcare professional before making any medical decisions or considering participation in a clinical trial.
Overview
Every clinical trial defines specific characteristics that participants must have (inclusion criteria) and characteristics that disqualify them (exclusion criteria). These criteria protect patient safety, ensure the study results are interpretable, and help researchers test their hypothesis in the right population. Understanding how to read eligibility criteria can save you significant time in your trial search.
1. Inclusion Criteria — Who Must Qualify
Inclusion criteria define the minimum requirements to join a trial. Common inclusion criteria include:
- Diagnosis: Specific condition, subtype, stage, or biomarker status (e.g., "HER2-positive breast cancer, Stage III or IV").
- Age range: Minimum and/or maximum age. Pediatric trials have strict age limits; some trials exclude people over 75 due to comorbidity concerns.
- Performance status: Functional ability scales like ECOG (0–4) or Karnofsky (0–100%) measure how well patients can carry out daily activities.
- Prior treatment: Some trials require prior lines of therapy ("must have received at least 2 prior chemotherapy regimens").
- Lab values: Adequate organ function (kidney, liver, bone marrow) as measured by specific blood test thresholds.
2. Exclusion Criteria — What Disqualifies You
Exclusion criteria are often longer than inclusion criteria and cover a wide range of safety and scientific concerns:
- Prior treatments: "No prior treatment with checkpoint inhibitors" — prevents confounding of results.
- Concurrent medications: Drugs that interact with the experimental treatment or affect the outcome being measured.
- Other medical conditions: Autoimmune diseases, active infections, cardiac conditions, or psychiatric disorders that could affect safety or confound outcomes.
- Pregnancy or breastfeeding: Standard exclusion in most interventional trials due to unknown fetal risk.
- Brain metastases: Often excluded from cancer trials unless the trial specifically addresses CNS disease.
- Recent surgery or other trials: Time-based exclusions ("no participation in another trial within 30 days").
3. Why These Criteria Exist
Eligibility criteria are not designed to be exclusionary — they exist for three core reasons:
- Safety: Protecting participants who might be at elevated risk of harm from the experimental intervention.
- Scientific validity: Enrolling a homogeneous population makes it possible to detect whether the treatment is causing the observed effects.
- Regulatory requirements: FDA and other agencies require well-defined populations in pivotal trials to support approval decisions.
4. What to Do If You Don't Qualify
- Contact the trial team anyway: Some criteria have flexibility. Protocol amendments sometimes occur. The coordinator may know of a sister trial for which you qualify.
- Search for similar trials: Use ClinicalMetric's condition pages to find related studies with different eligibility windows.
- Ask about compassionate use: For promising experimental therapies, the FDA's Expanded Access program may allow access outside a trial if you don't qualify for enrollment.
- Wait for Phase 3: If a Phase 2 trial excludes you, the Phase 3 trial often has broader eligibility criteria to reflect the general patient population more accurately.